PARP2 and cancer: Accordingly, elucidating the distinct regulatory roles of CSB in SSBR-mediated by PARP1 and PARP2 might uncover novel cancer therapeutic strategies that maximize PARPis’ efficacy with reduced toxicity to improve patient outcomes in cancer treatment.